Clinical Trials Logo

Metabolic Syndrome clinical trials

View clinical trials related to Metabolic Syndrome.

Filter by:
  • Active, not recruiting  
  • « Prev · Page 12

NCT ID: NCT00700024 Active, not recruiting - Metabolic Syndrome Clinical Trials

Odense Androgen Study - The Effect of Testim and Training in Hypogonadal Men

Start date: April 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the effect of training and testim on Hypogonadism.

NCT ID: NCT00518960 Active, not recruiting - Metabolic Syndrome Clinical Trials

The Effects of ProAlgaZyme on HDL Cholesterol in Individuals With Metabolic Syndrome

Start date: April 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effectiveness of ProAlgaZyme in increasing levels of HDL 'good' cholesterol and decreasing total cholesterol and C-reactive protein in patients with Metabolic Syndrome.

NCT ID: NCT00512070 Active, not recruiting - Obesity Clinical Trials

Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine

Start date: July 2007
Phase: N/A
Study type: Interventional

Atypical antipsychotic medications, such as olanzapine, cause metabolic side effects, including weight gain, extra fat around the middle of the body, high blood sugar, and high cholesterol. One of the mechanisms by which these medications may cause these effects is by reducing plasma melatonin. This study is a pilot project to evaluate 1) the effect of olanzapine on melatonin secretion levels and 2) the effect of melatonin on olanzapine-induced changes in melatonin secretion in patients with schizophrenia, schizoaffective, or bipolar disorder.

NCT ID: NCT00432952 Active, not recruiting - Clinical trials for Cardiovascular Diseases

Acute Single Meal Effects of Trout on Cardiovascular Risk Markers and Plasma Proteome

Start date: January 2007
Phase: N/A
Study type: Interventional

The acute effects of farmed rainbow trout, fed by various feeds versus a control meal with poultry meat on cardiovascular risk markers and plasma protein expression are investigated. The hypotheses of the study are that if the feed are changed from a marine origin to primarily a vegetable origin the content of long chain n-3 poly unsaturated fatty acids (n-3 PUFA) will decrease in the meat and thus possibly result in a decreased effect on health. Furthermore, the feed of the trouts are also expected to give rise to differences in the human plasma protein profile and fatty acid composition after consumption, which could be associated with physiological effects.

NCT ID: NCT00378820 Active, not recruiting - Obesity Clinical Trials

The Effect of Whey and Casein on IGFs in Prepubertal Boys

Start date: July 2004
Phase: N/A
Study type: Interventional

It is not clear which milk compounds are responsible for the growth stimulation. Through short term intervention studies in prepubertal children, we will test the effects of whey, casein, and milk minerals (especially Ca/P). Outcomes will be IGF-I, IGFBP-3, p-amino acids, oral glucose tolerance test (insulin, glucose, GLP-1 and 2, C-peptide, proinsulin) and markers for bone turn-over in blood and urine (s-osteocalcin, s-bone alkaline phosphatase, urine Dpyr, Ntx) as well as blood pressure.

NCT ID: NCT00350064 Active, not recruiting - Metabolic Syndrome Clinical Trials

Impact of Exercise Training Intensity on Abdominal Visceral Fat and Risk Factors Associated With the Metabolic Syndrome

Start date: April 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if sixteen weeks of high intensity physical training is more effective than sixteen weeks of low intensity physical training in reducing abdominal fat and lowering risk factors associated with the metabolic syndrome. Another aim of this study is to determine if high intensity physical training improves cognitive function.

NCT ID: NCT00292994 Active, not recruiting - Obesity Clinical Trials

Study of How Exercise or Weight Loss Effects Metabolic Syndrome

Start date: April 2004
Phase: N/A
Study type: Interventional

The Metabolic Syndrome (MS) is prevalent in the American population and is strongly associated with premature coronary disease. Lifestyle intervention, primarily exercise and dietary changes, are foundational treatment strategies for independent components of MS, but these interventions have not been thoroughly evaluated in MS. Even with very modest weight loss, in the setting of caloric restriction and exercise, marked improvement MS parameters have been noted. However, it is not known whether it is diet with weight loss or exercise that improves the metabolic derangements associated with MS. We propose a study designed to examine the relative impact of diet or exercise on the components of MS. Furthermore, it is known that psychological factors significantly impact the ability of patients to initiate and sustain lifestyle changes. We will monitor certain psychological states to evaluate their impact on the success of weight loss and sustainability of lifestyle changes throughout this study. Specific Aims: 1.) Evaluate the relative efficacy of diet with weight loss or exercise on improving the markers of metabolic syndrome. 2.) Determine of pre-existing psychological factors influence the effectiveness of diet with weight loss or exercise on the markers of metabolic syndrome. Design: Adult women (> 18 yrs) with a body-mass index (BMI)  30 kg/m2 will be assessed for MS and randomized to one of three groups (n = 34/group), Control (C), diet with weight loss alone (D), or exercise alone (E). The intervention groups will participate in supervised dietary changes designed for weight loss or exercise for 6 months. Anthropomorphic, serologic, and psychological parameters will be monitored and compared using ANOVA. Hypothesis: As indexed by the improvement in the laboratory markers of the components of metabolic syndrome, exercise alone has a more profound positive impact on Metabolic Syndrome then diet with weight loss alone.

NCT ID: NCT00266292 Active, not recruiting - Metabolic Syndrome Clinical Trials

The Effect of n-3 LCPUFA on Immune Function and Cardiovascular Risk Factors

Start date: September 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effects of long-chain n-3 polyunsaturated fatty acids (n-3 LCPUFA) on immune function and cardiovascular disease risk